Search research articles
Contact Us
Filters
Showing results (51-60 of 412) with videos related to
Page
of 42
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2022
Ki67 as a Companion Diagnostic: Good or Bad News?
Mitch Dowsett, Torsten O Nielsen, David L Rimm, et al.
Human Pathology
|
April 15, 2026
Pathological Response to Herceptin-containing Neoadjuvant Therapy in HER2 IHC2+/ISH+ and IHC3+ Early-Stage Invasive Ductal Carcinoma
Tristan Jordan, Nay Nwe Nyein Chan, David L Rimm, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 30, 2007
Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model
Sharon Pozner-Moulis, Melissa Cregger, Robert L Camp, et al.
Journal of the National Cancer Institute
|
December 22, 2005
Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis
Anthony McCabe, Marisa Dolled-Filhart, Robert L Camp, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
July 24, 2012
Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5
Allison W Welsh, Malini Harigopal, Hallie Wimberly, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 7, 2020
Digital quantitative assessment of PD-L1 using digital spatial profiling
Swati Gupta, Jon Zugazagoitia, Sandra Martinez-Morilla, et al.
Nature Reviews. Clinical Oncology
|
August 11, 2019
Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology
Kaustav Bera, Kurt A Schalper, David L Rimm, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 22, 2009
Quantitative, fluorescence-based in-situ assessment of protein expression
Christopher B Moeder, Jennifer M Giltnane, Sharon Pozner Moulis, et al.
Archives of Pathology & Laboratory Medicine
|
October 30, 2013
A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologists criteria
Kurt A Schalper, Sudha Kumar, Pei Hui, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 15, 2004
Long-term preservation of antigenicity on tissue microarrays
Kyle A DiVito, Lori A Charette, David L Rimm, et al.
Page
of 42
Search research articles
Search
Showing results (51-60 of 412) with videos related to
Sort By:
Page
of 42
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2022
Ki67 as a Companion Diagnostic: Good or Bad News?
Mitch Dowsett, Torsten O Nielsen, David L Rimm, et al.
Human Pathology
|
April 15, 2026
Pathological Response to Herceptin-containing Neoadjuvant Therapy in HER2 IHC2+/ISH+ and IHC3+ Early-Stage Invasive Ductal Carcinoma
Tristan Jordan, Nay Nwe Nyein Chan, David L Rimm, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 30, 2007
Antibody validation by quantitative analysis of protein expression using expression of Met in breast cancer as a model
Sharon Pozner-Moulis, Melissa Cregger, Robert L Camp, et al.
Journal of the National Cancer Institute
|
December 22, 2005
Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis
Anthony McCabe, Marisa Dolled-Filhart, Robert L Camp, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
July 24, 2012
Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5
Allison W Welsh, Malini Harigopal, Hallie Wimberly, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 7, 2020
Digital quantitative assessment of PD-L1 using digital spatial profiling
Swati Gupta, Jon Zugazagoitia, Sandra Martinez-Morilla, et al.
Nature Reviews. Clinical Oncology
|
August 11, 2019
Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology
Kaustav Bera, Kurt A Schalper, David L Rimm, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
April 22, 2009
Quantitative, fluorescence-based in-situ assessment of protein expression
Christopher B Moeder, Jennifer M Giltnane, Sharon Pozner Moulis, et al.
Archives of Pathology & Laboratory Medicine
|
October 30, 2013
A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologists criteria
Kurt A Schalper, Sudha Kumar, Pei Hui, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 15, 2004
Long-term preservation of antigenicity on tissue microarrays
Kyle A DiVito, Lori A Charette, David L Rimm, et al.
Page
of 42